Press Releases

Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101

Patent developed in collaboration with Syngene International Ltd

Panbela Schedules Conference Call on August 11 to Report 2021 Second Quarter Financial Results

Panbela to Present at Access to Giving Virtual Conference July 15 at 10:30 a.m. ET

Panbela Announces Closing of $10.0 Million Bought Deal Offering of Common Stock

Panbela Increases Previously Announced Bought Deal Offering of Common Stock to $10.0 Million

Panbela Announces $5.0 Million Bought Deal Offering of Common Stock

Panbela Set to Join Russell Microcap® Index

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting

Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors

Panbela Provides Business Update and Reports Q1 2021 Financial Results